• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Amgen

Amgen

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs

    Amgen to Help Develop Novartis's Pipeline of Alzheimer's Drugs

  2. FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab)

    FDA Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab)

  3. Amgen gets FDA approval for new cholesterol treatment

    Amgen gets FDA approval for new cholesterol treatment

  4. FDA Approves Amgen's Cholesterol-Lowering Drug Repatha -- Update

    FDA Approves Amgen's Cholesterol-Lowering Drug Repatha -- Update

  5. FDA Approves Amgen's Repatha Cholesterol Drug

    FDA Approves Amgen's Repatha Cholesterol Drug

  6. FDA Approves New Amgen Cholesterol Drug

    FDA Approves New Amgen Cholesterol Drug

  7. Valeant Strikes Psoriasis-Drug Pact With AstraZeneca -- Update

    Valeant Strikes Psoriasis-Drug Pact With AstraZeneca -- Update

  8. Valeant Strikes Psoriasis-Drug Pact With AstraZeneca

    Valeant Strikes Psoriasis-Drug Pact With AstraZeneca

  9. Valeant Strikes Psoriasis-Drug Pact With AstraZeneca

    Valeant Strikes Psoriasis-Drug Pact With AstraZeneca

  10. Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights

    Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.